NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs021190011

Registered date:13/11/2019

SWORD C Study

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedirritable bowel syndrome
Date of first enrollment07/07/2020
Target sample size68
Countries of recruitment
Study typeInterventional
Intervention(s)A: Yokukansankachimpihange 7.5 g per day for 12 weeks B: Potato starch 7.5 g per day for 12 weeks

Outcome(s)

Primary OutcomeChange from baseline in outcome of STAI State Anxiety Inventory score at 12weeks
Secondary Outcome1. STAI Trait Anxiety Inventory score 2. HADS score 3. IBS-QOL score 4. Daily number of stools 5. Stool consistency 6. Abdominal pain severity, abdominal fullness, anxiety score 7. Improvement rates of abdominal pain severity, abdominal fullness, Anxiety score 8. Insomnia Severity Index

Key inclusion & exclusion criteria

Age minimum>= 16age old
Age maximum<= 75age old
GenderBoth
Include criteria1. Patients with IBS diagnosed with Rome IV criteria 2. Patients treated at the 1st step in clinical practice guideline of JSGE 2014 at least 4 weeks before randomization. 3. Condition with STAI-state score >= 41 4. Aged 16-75 years at the time of informed consent 5. Provision of written informed consent
Exclude criteria1. Major abdominal surgery (except appendectomy or hysterectomy) 2. History of inflammatory bowel disease, ischemic colitis, malignant tumor 3. Severe neurological complications (Parkinson's disease, Shy-Drager syndrome, schizophrenia, bipolar disorder) 4. Use of Kampo within 4 weeks prior to randomization 5. Allergy to Kampo 6. Lactose intolerance 7. Allergy to Starch 8. Severe complications (hepatic diseases, serious cardiovascular diseases, hematological diseases, metabolic diseases or malignant neoplasms) 9. Pregnancy, breastfeeding or planning on becoming pregnant throughout the course of the study 10. Unable to take MRI 11. Lack of suitability for participation in the study for any reason as judged by the investigator

Related Information

Contact

Public contact
Name Motoyori Kanazawa
Address 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan Miyagi Japan 980-8574
Telephone +81-22-717-7327
E-mail m-kanazawa@med.tohoku.ac.jp
Affiliation Tohoku University Hospital
Scientific contact
Name Shin Fukudo
Address 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan Miyagi Japan 980-8574
Telephone +81-90-4885-6083
E-mail sfukudo@med.tohoku.ac.jp
Affiliation Tohoku University Hospital